C3 and glaucoma: This shows that not only the C3-dependent pathway but also the C3-independent pathway should be considered in therapeutic modulation of the complement system, especially since not only C3 but also C1q was up-regulated in early stages of glaucoma in different cell types such as retinal ganglion cells as well as in the optic nerve head [177].